annual FCF:
-$53.14M+$44.16M(+45.39%)Summary
- As of today (May 29, 2025), BCRX annual free cash flow is -$53.14 million, with the most recent change of +$44.16 million (+45.39%) on December 31, 2024.
- During the last 3 years, BCRX annual FCF has risen by +$91.40 million (+63.23%).
- BCRX annual FCF is now -1055.30% below its all-time high of -$4.60 million, reached on December 31, 1998.
Performance
BCRX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$27.66M-$21.77M(-369.77%)Summary
- As of today (May 29, 2025), BCRX quarterly free cash flow is -$27.66 million, with the most recent change of -$21.77 million (-369.77%) on March 31, 2025.
- Over the past year, BCRX quarterly FCF has increased by +$26.26 million (+48.70%).
- BCRX quarterly FCF is now -207.40% below its all-time high of $25.75 million, reached on March 31, 2006.
Performance
BCRX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$26.89M+$26.26M(+49.41%)Summary
- As of today (May 29, 2025), BCRX TTM free cash flow is -$26.89 million, with the most recent change of +$26.26 million (+49.41%) on March 31, 2025.
- Over the past year, BCRX TTM FCF has increased by +$76.67 million (+74.04%).
- BCRX TTM FCF is now -438.77% below its all-time high of $7.94 million, reached on March 31, 2006.
Performance
BCRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BCRX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.4% | +48.7% | +74.0% |
| 3 y3 years | +63.2% | +64.6% | +83.4% |
| 5 y5 years | +40.9% | -18.2% | +68.8% |
BCRX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.4% | -437.9% | +64.6% | at high | +84.4% |
| 5 y | 5-year | at high | +67.4% | -437.9% | +64.6% | at high | +84.5% |
| alltime | all time | -1055.3% | +67.4% | -207.4% | +64.6% | -438.8% | +84.5% |
BCRX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$27.66M(+369.8%) | -$26.89M(-49.4%) |
| Dec 2024 | -$53.14M(-45.4%) | -$5.89M(-171.9%) | -$53.14M(-6.3%) |
| Sep 2024 | - | $8.19M(-637.5%) | -$56.73M(-33.9%) |
| Jun 2024 | - | -$1.52M(-97.2%) | -$85.80M(-17.1%) |
| Mar 2024 | - | -$53.92M(+469.2%) | -$103.56M(+6.4%) |
| Dec 2023 | -$97.31M(-40.4%) | -$9.47M(-54.6%) | -$97.31M(-13.3%) |
| Sep 2023 | - | -$20.88M(+8.3%) | -$112.21M(-9.5%) |
| Jun 2023 | - | -$19.28M(-59.6%) | -$123.95M(-6.6%) |
| Mar 2023 | - | -$47.67M(+95.6%) | -$132.67M(-18.7%) |
| Dec 2022 | -$163.20M(+12.9%) | -$24.38M(-25.3%) | -$163.20M(-5.3%) |
| Sep 2022 | - | -$32.62M(+16.5%) | -$172.39M(+5.5%) |
| Jun 2022 | - | -$28.00M(-64.2%) | -$163.41M(+1.1%) |
| Mar 2022 | - | -$78.21M(+133.0%) | -$161.64M(+11.8%) |
| Dec 2021 | -$144.54M(+6.6%) | -$33.57M(+42.0%) | -$144.54M(-5.9%) |
| Sep 2021 | - | -$23.64M(-9.8%) | -$153.66M(-8.8%) |
| Jun 2021 | - | -$26.22M(-57.1%) | -$168.45M(-2.8%) |
| Mar 2021 | - | -$61.11M(+43.2%) | -$173.34M(+27.8%) |
| Dec 2020 | -$135.62M(+50.8%) | -$42.69M(+11.1%) | -$135.62M(+31.1%) |
| Sep 2020 | - | -$38.43M(+23.5%) | -$103.46M(+11.5%) |
| Jun 2020 | - | -$31.11M(+33.0%) | -$92.76M(+7.6%) |
| Mar 2020 | - | -$23.40M(+122.2%) | -$86.23M(-4.1%) |
| Dec 2019 | -$89.93M(-3.2%) | -$10.53M(-62.0%) | -$89.93M(-13.1%) |
| Sep 2019 | - | -$27.72M(+12.7%) | -$103.49M(-6.6%) |
| Jun 2019 | - | -$24.59M(-9.2%) | -$110.84M(+10.5%) |
| Mar 2019 | - | -$27.09M(+12.5%) | -$100.33M(+8.0%) |
| Dec 2018 | -$92.93M(+124.1%) | -$24.09M(-31.3%) | -$92.93M(+16.9%) |
| Sep 2018 | - | -$35.07M(+149.1%) | -$79.48M(+39.4%) |
| Jun 2018 | - | -$14.08M(-28.5%) | -$57.02M(+8.3%) |
| Mar 2018 | - | -$19.69M(+85.1%) | -$52.63M(+26.9%) |
| Dec 2017 | -$41.47M(-29.4%) | -$10.63M(-15.7%) | -$41.47M(+13.0%) |
| Sep 2017 | - | -$12.62M(+30.3%) | -$36.69M(-12.2%) |
| Jun 2017 | - | -$9.69M(+13.6%) | -$41.81M(-7.4%) |
| Mar 2017 | - | -$8.53M(+45.7%) | -$45.14M(-23.1%) |
| Dec 2016 | -$58.72M(+221.9%) | -$5.85M(-67.0%) | -$58.72M(-18.2%) |
| Sep 2016 | - | -$17.74M(+36.2%) | -$71.74M(+7.4%) |
| Jun 2016 | - | -$13.02M(-41.1%) | -$66.80M(+85.3%) |
| Mar 2016 | - | -$22.10M(+17.1%) | -$36.05M(+97.7%) |
| Dec 2015 | -$18.24M(-52.8%) | -$18.87M(+47.4%) | -$18.24M(+36.9%) |
| Sep 2015 | - | -$12.80M(-172.2%) | -$13.32M(+45.5%) |
| Jun 2015 | - | $17.73M(-513.2%) | -$9.15M(-73.1%) |
| Mar 2015 | - | -$4.29M(-69.3%) | -$33.98M(-12.1%) |
| Dec 2014 | -$38.66M(+45.5%) | -$13.96M(+61.6%) | -$38.66M(+32.3%) |
| Sep 2014 | - | -$8.63M(+21.6%) | -$29.22M(+2.5%) |
| Jun 2014 | - | -$7.10M(-20.8%) | -$28.51M(+17.2%) |
| Mar 2014 | - | -$8.97M(+98.4%) | -$24.33M(-8.4%) |
| Dec 2013 | -$26.56M(-29.2%) | -$4.52M(-43.0%) | -$26.56M(-8.6%) |
| Sep 2013 | - | -$7.92M(+171.2%) | -$29.07M(-11.7%) |
| Jun 2013 | - | -$2.92M(-73.9%) | -$32.93M(-9.5%) |
| Mar 2013 | - | -$11.20M(+59.3%) | -$36.39M(-3.0%) |
| Dec 2012 | -$37.51M(+16.1%) | -$7.03M(-40.4%) | -$37.51M(+8.8%) |
| Sep 2012 | - | -$11.78M(+84.6%) | -$34.47M(+4.0%) |
| Jun 2012 | - | -$6.38M(-48.2%) | -$33.15M(+9.5%) |
| Mar 2012 | - | -$12.32M(+209.1%) | -$30.27M(-6.3%) |
| Dec 2011 | -$32.31M(+11.9%) | -$3.98M(-61.9%) | -$32.31M(-5.4%) |
| Sep 2011 | - | -$10.47M(+199.7%) | -$34.15M(+3.6%) |
| Jun 2011 | - | -$3.49M(-75.7%) | -$32.98M(-13.1%) |
| Mar 2011 | - | -$14.36M(+146.1%) | -$37.97M(+31.5%) |
| Dec 2010 | -$28.88M(+71.7%) | -$5.83M(-37.2%) | -$28.88M(+113.9%) |
| Sep 2010 | - | -$9.29M(+9.5%) | -$13.50M(+42.5%) |
| Jun 2010 | - | -$8.48M(+60.9%) | -$9.48M(-26.8%) |
| Mar 2010 | - | -$5.27M(-155.2%) | -$12.94M(-23.1%) |
| Dec 2009 | -$16.82M | $9.54M(-281.2%) | -$16.82M(-45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$5.27M(-55.9%) | -$30.98M(-3.4%) |
| Jun 2009 | - | -$11.94M(+30.5%) | -$32.08M(+20.7%) |
| Mar 2009 | - | -$9.15M(+98.6%) | -$26.58M(+20.3%) |
| Dec 2008 | -$22.09M(-22.1%) | -$4.61M(-27.6%) | -$22.09M(-36.9%) |
| Sep 2008 | - | -$6.37M(-1.2%) | -$34.97M(+1.2%) |
| Jun 2008 | - | -$6.45M(+38.2%) | -$34.56M(+17.8%) |
| Mar 2008 | - | -$4.67M(-73.3%) | -$29.33M(+3.5%) |
| Dec 2007 | -$28.34M(+69.2%) | -$17.50M(+194.0%) | -$28.34M(+7.7%) |
| Sep 2007 | - | -$5.95M(+389.1%) | -$26.32M(-21.6%) |
| Jun 2007 | - | -$1.22M(-66.9%) | -$33.56M(-27.3%) |
| Mar 2007 | - | -$3.67M(-76.3%) | -$46.17M(+175.7%) |
| Dec 2006 | -$16.75M(-28.4%) | -$15.47M(+17.2%) | -$16.75M(+142.8%) |
| Sep 2006 | - | -$13.20M(-4.5%) | -$6.90M(<-9900.0%) |
| Jun 2006 | - | -$13.83M(-153.7%) | $61.10K(-99.2%) |
| Mar 2006 | - | $25.75M(-557.9%) | $7.94M(-133.9%) |
| Dec 2005 | -$23.40M(+27.0%) | -$5.62M(-9.9%) | -$23.40M(+0.4%) |
| Sep 2005 | - | -$6.24M(+4.9%) | -$23.30M(+11.2%) |
| Jun 2005 | - | -$5.95M(+6.7%) | -$20.94M(+6.5%) |
| Mar 2005 | - | -$5.58M(+0.9%) | -$19.66M(+6.7%) |
| Dec 2004 | -$18.43M(+63.8%) | -$5.53M(+42.1%) | -$18.43M(+17.9%) |
| Sep 2004 | - | -$3.89M(-16.8%) | -$15.63M(+5.8%) |
| Jun 2004 | - | -$4.67M(+7.6%) | -$14.77M(+14.4%) |
| Mar 2004 | - | -$4.34M(+59.3%) | -$12.91M(+14.8%) |
| Dec 2003 | -$11.25M(-32.9%) | -$2.73M(-10.2%) | -$11.25M(+4.4%) |
| Sep 2003 | - | -$3.03M(+8.0%) | -$10.77M(-3.0%) |
| Jun 2003 | - | -$2.81M(+4.8%) | -$11.10M(-15.7%) |
| Mar 2003 | - | -$2.68M(+19.1%) | -$13.17M(-21.5%) |
| Dec 2002 | -$16.77M(+31.4%) | -$2.25M(-33.1%) | -$16.77M(-9.7%) |
| Sep 2002 | - | -$3.36M(-31.1%) | -$18.58M(+0.5%) |
| Jun 2002 | - | -$4.88M(-22.3%) | -$18.49M(+14.1%) |
| Mar 2002 | - | -$6.28M(+54.9%) | -$16.20M(+26.9%) |
| Dec 2001 | -$12.76M(+116.3%) | -$4.06M(+23.9%) | -$12.76M(+10.0%) |
| Sep 2001 | - | -$3.27M(+26.4%) | -$11.60M(+2.2%) |
| Jun 2001 | - | -$2.59M(-8.8%) | -$11.34M(+4.8%) |
| Mar 2001 | - | -$2.84M(-1.7%) | -$10.82M(+83.4%) |
| Dec 2000 | -$5.90M(+0.0%) | -$2.89M(-4.3%) | -$5.90M(+54.9%) |
| Sep 2000 | - | -$3.02M(+46.2%) | -$3.81M(+27.5%) |
| Jun 2000 | - | -$2.07M(-199.5%) | -$2.99M(+192.5%) |
| Mar 2000 | - | $2.08M(-359.8%) | -$1.02M(-82.7%) |
| Dec 1999 | -$5.90M(+28.3%) | -$800.00K(-63.6%) | -$5.90M(+490.0%) |
| Sep 1999 | - | -$2.20M(+2100.0%) | -$1.00M(-41.2%) |
| Jun 1999 | - | -$100.00K(-96.4%) | -$1.70M(-63.0%) |
| Mar 1999 | - | -$2.80M(-168.3%) | -$4.60M(0.0%) |
| Dec 1998 | -$4.60M(-59.6%) | $4.10M(-241.4%) | -$4.60M(-61.0%) |
| Sep 1998 | - | -$2.90M(-3.3%) | -$11.80M(+2.6%) |
| Jun 1998 | - | -$3.00M(+7.1%) | -$11.50M(+7.5%) |
| Mar 1998 | - | -$2.80M(-9.7%) | -$10.70M(-6.1%) |
| Dec 1997 | -$11.40M(+60.6%) | -$3.10M(+19.2%) | -$11.40M(+14.0%) |
| Sep 1997 | - | -$2.60M(+18.2%) | -$10.00M(+2.0%) |
| Jun 1997 | - | -$2.20M(-37.1%) | -$9.80M(+14.0%) |
| Mar 1997 | - | -$3.50M(+105.9%) | -$8.60M(+21.1%) |
| Dec 1996 | -$7.10M(-10.1%) | -$1.70M(-29.2%) | -$7.10M(+1.4%) |
| Sep 1996 | - | -$2.40M(+140.0%) | -$7.00M(+7.7%) |
| Jun 1996 | - | -$1.00M(-50.0%) | -$6.50M(-3.0%) |
| Mar 1996 | - | -$2.00M(+25.0%) | -$6.70M(-15.2%) |
| Dec 1995 | -$7.90M(+14.5%) | -$1.60M(-15.8%) | -$7.90M(0.0%) |
| Sep 1995 | - | -$1.90M(+58.3%) | -$7.90M(-1.3%) |
| Jun 1995 | - | -$1.20M(-62.5%) | -$8.00M(-3.6%) |
| Mar 1995 | - | -$3.20M(+100.0%) | -$8.30M(+20.3%) |
| Dec 1994 | -$6.90M | -$1.60M(-20.0%) | -$6.90M(+30.2%) |
| Sep 1994 | - | -$2.00M(+33.3%) | -$5.30M(+60.6%) |
| Jun 1994 | - | -$1.50M(-16.7%) | -$3.30M(+83.3%) |
| Mar 1994 | - | -$1.80M | -$1.80M |
FAQ
- What is BioCryst Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual FCF year-on-year change?
- What is BioCryst Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly FCF year-on-year change?
- What is BioCryst Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM FCF year-on-year change?
What is BioCryst Pharmaceuticals annual free cash flow?
The current annual FCF of BCRX is -$53.14M
What is the all time high annual FCF for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual free cash flow is -$4.60M
What is BioCryst Pharmaceuticals annual FCF year-on-year change?
Over the past year, BCRX annual free cash flow has changed by +$44.16M (+45.39%)
What is BioCryst Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of BCRX is -$27.66M
What is the all time high quarterly FCF for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly free cash flow is $25.75M
What is BioCryst Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, BCRX quarterly free cash flow has changed by +$26.26M (+48.70%)
What is BioCryst Pharmaceuticals TTM free cash flow?
The current TTM FCF of BCRX is -$26.89M
What is the all time high TTM FCF for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM free cash flow is $7.94M
What is BioCryst Pharmaceuticals TTM FCF year-on-year change?
Over the past year, BCRX TTM free cash flow has changed by +$76.67M (+74.04%)